Seksuelle bivirkninger ved SSRI

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

Seksuelle bivirkninger ved SSRI. / Hutters, Cecilie Lybeck; Giraldi, Annamaria.

I: Ugeskrift for Laeger, Bind 184, Nr. 14, V11210824, 04.04.2022.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

Hutters, CL & Giraldi, A 2022, 'Seksuelle bivirkninger ved SSRI', Ugeskrift for Laeger, bind 184, nr. 14, V11210824. <https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-03/v11210824_web.pdf>

APA

Hutters, C. L., & Giraldi, A. (2022). Seksuelle bivirkninger ved SSRI. Ugeskrift for Laeger, 184(14), [V11210824]. https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-03/v11210824_web.pdf

Vancouver

Hutters CL, Giraldi A. Seksuelle bivirkninger ved SSRI. Ugeskrift for Laeger. 2022 apr. 4;184(14). V11210824.

Author

Hutters, Cecilie Lybeck ; Giraldi, Annamaria. / Seksuelle bivirkninger ved SSRI. I: Ugeskrift for Laeger. 2022 ; Bind 184, Nr. 14.

Bibtex

@article{666fae29f62e47bfa2775982bdcbe58f,
title = "Seksuelle bivirkninger ved SSRI",
abstract = "Treatment with SSRI have a high frequency of treatment of emergent sexual dysfunction. The mechanism is thought to be through serotoninergic inhibition of the sexual response. More than 70% of patients treated with sertraline, citalopram or paroxetine experience sexual side effects, while escitalopram and fluvoxamine yield the lowest degree of sexual dysfunction within the group. This review suggests management strategies including dose reduction, change of medication and add-on treatment. A small group of patients experience post-SSRI dysfunction, in which sexual dysfunction persists after treatment termination.",
keywords = "Citalopram/adverse effects, Humans, Paroxetine/adverse effects, Serotonin Uptake Inhibitors/adverse effects, Sertraline/adverse effects, Sexual Dysfunction, Physiological/chemically induced",
author = "Hutters, {Cecilie Lybeck} and Annamaria Giraldi",
year = "2022",
month = apr,
day = "4",
language = "Dansk",
volume = "184",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "14",

}

RIS

TY - JOUR

T1 - Seksuelle bivirkninger ved SSRI

AU - Hutters, Cecilie Lybeck

AU - Giraldi, Annamaria

PY - 2022/4/4

Y1 - 2022/4/4

N2 - Treatment with SSRI have a high frequency of treatment of emergent sexual dysfunction. The mechanism is thought to be through serotoninergic inhibition of the sexual response. More than 70% of patients treated with sertraline, citalopram or paroxetine experience sexual side effects, while escitalopram and fluvoxamine yield the lowest degree of sexual dysfunction within the group. This review suggests management strategies including dose reduction, change of medication and add-on treatment. A small group of patients experience post-SSRI dysfunction, in which sexual dysfunction persists after treatment termination.

AB - Treatment with SSRI have a high frequency of treatment of emergent sexual dysfunction. The mechanism is thought to be through serotoninergic inhibition of the sexual response. More than 70% of patients treated with sertraline, citalopram or paroxetine experience sexual side effects, while escitalopram and fluvoxamine yield the lowest degree of sexual dysfunction within the group. This review suggests management strategies including dose reduction, change of medication and add-on treatment. A small group of patients experience post-SSRI dysfunction, in which sexual dysfunction persists after treatment termination.

KW - Citalopram/adverse effects

KW - Humans

KW - Paroxetine/adverse effects

KW - Serotonin Uptake Inhibitors/adverse effects

KW - Sertraline/adverse effects

KW - Sexual Dysfunction, Physiological/chemically induced

M3 - Review

C2 - 35410653

VL - 184

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 14

M1 - V11210824

ER -

ID: 325710971